These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1337178)

  • 1. Towards defining antigens in human membranous nephropathy.
    Brenchley PE; Short CD; Feehally J; Mallick NP
    Nephrol Dial Transplant; 1992; 7 Suppl 1():21-4. PubMed ID: 1337178
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies to glomerular antigens.
    Ronco P; Sahali D; Cittanova ML; van Leer EH; Chatelet F; Verroust P
    Nephrol Dial Transplant; 1992; 7 Suppl 1():9-15. PubMed ID: 1362802
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro solubilization of glomerular immune deposits after incubation with human IgG and IgA in membranous and IgA nephropathy.
    Cirami C; Finato V; Andreini B; Bianchi AM; Panichi V; Montagnani E; Parrini M; Gattai V; Casarosa L; Palla R
    Clin Nephrol; 1993 Sep; 40(3):185. PubMed ID: 8403576
    [No Abstract]   [Full Text] [Related]  

  • 4. Membranous nephropathy: a long road but well traveled.
    Couser WG
    J Am Soc Nephrol; 2005 May; 16(5):1184-7. PubMed ID: 15800114
    [No Abstract]   [Full Text] [Related]  

  • 5. Presence of circulating antibodies against brush border antigens (Fx1A) in a patient with membranous nephropathy and bilateral pyeloureteral stenosis. Comparison with idiopathic membranous nephropathy.
    González-Cabrero J; de Nicolas R; Ortíz A; Mampaso F; Hernando L; Egido J
    Nephrol Dial Transplant; 1992; 7(4):293-9. PubMed ID: 1317518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
    Kerjaschki D
    Verh Dtsch Ges Pathol; 1989; 73():24-35. PubMed ID: 2482609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of an antigen distinct from the Heymann antigen in membranous glomerulonephritis in the mouse.
    Assmann KJ; Ronco P; Tangelder MM; Lange WP; Verroust P; Koene RA
    Lab Invest; 1989 Jan; 60(1):138-46. PubMed ID: 2642986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heymann nephritis: a model of human membranous glomerulopathy. A study of the role of additional antigens.
    van Leer EH; Ronco P; Verroust P; de Roo GM; Hoedemaeker PJ; de Heer E
    Nephrol Dial Transplant; 1992; 7 Suppl 1():1-8. PubMed ID: 1362800
    [No Abstract]   [Full Text] [Related]  

  • 9. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.
    Debiec H; Ronco P
    N Engl J Med; 2011 Feb; 364(7):689-90. PubMed ID: 21323563
    [No Abstract]   [Full Text] [Related]  

  • 10. Reactivity of monoclonal antibody P1 with glomerular basement membrane in thin-membrane nephropathy.
    Dische FE; Brooke IP; Cashman SJ; Severn A; Taube D; Parsons V; Kershaw M; Reed A; Pusey CD
    Nephrol Dial Transplant; 1989; 4(7):611-7. PubMed ID: 2510058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heymann nephritis revisited--new insights into the pathogenesis of experimental membranous glomerulonephritis.
    De Heer E; Bruijn JA; Hoedemaeker PJ
    Clin Exp Immunol; 1993 Dec; 94(3):393-4. PubMed ID: 8252799
    [No Abstract]   [Full Text] [Related]  

  • 12. Idiopathic membranous nephropathy (IMN) in two HLA-identical brothers with different outcome of the disease.
    Grcevska L; Polenakovic M
    Clin Nephrol; 1999 Sep; 52(3):194-6. PubMed ID: 10499319
    [No Abstract]   [Full Text] [Related]  

  • 13. Megalin/GP330 and pathogenetic concepts of membranous glomerulopathy (MGN).
    Kerjaschki D
    Kidney Blood Press Res; 2000; 23(3-5):163-6. PubMed ID: 11031710
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antinuclear antibodies in IgA nephropathy, as well as mesangiocapillary and membranous glomerulonephritis].
    Nagy J; Goshen E; Livne A; Sarov I; Shoenfeld Y
    Orv Hetil; 1991 Mar; 132(12):623-8. PubMed ID: 2011384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of C5b-9 in experimental membranous nephropathy.
    Couser WG; Schulze M; Pruchno CJ
    Nephrol Dial Transplant; 1992; 7 Suppl 1():25-31. PubMed ID: 1337179
    [No Abstract]   [Full Text] [Related]  

  • 16. Crescentic transformation in primary membranous glomerulopathy: association with anti-GBM antibody.
    Nayak SG; Satish R
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):599-602. PubMed ID: 17951950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis and membranous glomerulonephropathy.
    Taniguchi Y; Yorioka N; Kumagai J; Ito T; Yamakido M; Taguchi T
    Clin Nephrol; 1999 Oct; 52(4):253-5. PubMed ID: 10543328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential localization of s and e antigens in hepatitis B virus-associated glomerulonephritis.
    Ohba S; Kimura K; Mise N; Konno Y; Suzuki N; Miyashita K; Tojo A; Hirata Y; Uehara Y; Atarashi K; Goto A; Omata M
    Clin Nephrol; 1997 Jul; 48(1):44-7. PubMed ID: 9247778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
    Ronco P; Allegri L; Brianti E; Chatelet F; Van Leer EH; Verroust P
    Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic membranous nephropathy in 2 twin brothers.
    Vangelista A; Tazzari R; Bonomini V
    Nephron; 1988; 50(1):79-80. PubMed ID: 3173611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.